Transferability indices for health economic evaluations: methods and applications
- 7 May 2009
- journal article
- research article
- Published by Wiley in Health Economics
- Vol. 18 (6) , 629-643
Abstract
In this paper, we have elaborated an index in two phases to measure the degree of transferability of the results of the economic evaluation of health technologies. In the first phase, we have considered the objective factors (critical and non‐critical) to derive a general transferability index, which can be used to measure this internal property of the studies of economic evaluation applied to health technologies. In the second phase, with a more specific index, we have measured the degree of applicability of the results of a given study to a different setting. Both indices have been combined (arithmetic and geometric mean) to obtain a global transferability index. We have applied the global index to a sample of 27 Spanish studies on infectious diseases. We have obtained an average value for the index of 0.54, quite far from the maximum theoretical value of 1. We also found that 11 studies lacked some critical factor and were directly deemed as not transferable. Copyright © 2008 John Wiley & Sons, Ltd.Keywords
This publication has 27 references indexed in Scilit:
- The Generalisability of Pharmacoeconomic StudiesPharmacoEconomics, 2006
- Can economic evaluations be made more transferable?The European Journal of Health Economics, 2005
- Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE studyCurrent Medical Research and Opinion, 2005
- Análisis farmacoeconómico del tratamiento de pacientes con exacerbación aguda de la bronquitis crónica con telitromicina o cefuroxima-axetiloRevista Clínica Española, 2004
- Assessing generalisability by location in trial‐based cost‐effectiveness analysis: the use of multilevel modelsHealth Economics, 2004
- A Decision Chart for Assessing and Improving the Transferability of Economic Evaluation Results Between CountriesPharmacoEconomics, 2004
- Assessing the appropriateness of combining economic data from multinational clinical trialsStatistics in Medicine, 2003
- Do Health-Care Decision Makers Find Economic Evaluations Useful? The Findings of Focus Group Research in UK Health AuthoritiesValue in Health, 2002
- Diagnosis of Helicobacter pylori after triple therapy in uncomplicated duodenal ulcers—a cost‐effectiveness analysisAlimentary Pharmacology & Therapeutics, 2000
- Review of European guidelines for economic evaluation of medical technologies and pharmaceuticalsHEPAC Health Economics in Prevention and Care, 2000